Table 3.

Solicited local and systemic adverse events within seven days after GC501 vaccination

^*Data are presented as proportion (95% confidence interval) of participants who reported having a solicited local or systemic adverse event. Pain was grade 0 (absent), grade 1 (does not interfere with activity), grade 2 (repeated use of non-narcotic pain reliever > 24 hr or interferes with activity), grade 3 (any use of narcotic pain reliever or prevents daily activity), or grade 4 (emergency room visit or hospitalization). Tenderness was grade 0 (absent), grade 1 (mild discomfort to touch), grade 2 (discomfort with movement), grade 3 (significant discomfort at rest), or grade 4 (emergency room visit or hospitalization). Other adverse events were grade 1 (does not interfere with activity), grade 2 (interferes with activity), grade 3 (prevents daily activity), or grade 4 (emergency room visit or hospitalization).